US Bans Chinese Robot Imports, Boosting K-Humanoid Prospects

*Editor's Note: 'AI PRISM' (Personalized Report & Insight Summarizing Media) is an 'AI-based customized news recommendation and summary service' developed with support from the Korea Press Foundation. It selects and provides six customized news items by reader type.

1. US Bars Chinese Advanced Robots, K-Component Firms Eye the Gap

- Key Summary: The US Federal Communications Commission (FCC) fully banned imports of new models of humanoid robots and quadruped robots on the 28th of last month, directly targeting Chinese-made robots. As a result, Halla Cast will double its robot thermal management component production line at its Incheon plant and begin supplying North American companies from the second half of this year. SL will begin full-scale mass production of leg modules for Boston Dynamics' quadruped robot 'Spot' during the third quarter, while Samhyun sought collaboration with local companies at a Silicon Valley exhibition. Goldman Sachs forecast that Korea will establish itself as a key country producing 74,000 units, or 30% of the world's humanoid production, by 2030.

2. Digital Twin Slashes Defects 13%: "AI Finds Optimal Painting Conditions"

- Key Summary: Korea Alps, a mid-sized component company with 40 years of history, is optimizing the painting process for automotive electronic components by integrating AI with digital twin technology. As a result, daily output rose about 5% from approximately 45,000 units to 47,250 units, and painting process defects fell 13%. In addition, the preparation period for new product production was shortened from around two months to nearly two weeks, and quality inspection personnel were reduced from 75 to 71. Korea Alps has already accumulated more than 710,000 process scenario data points and has been designated a regional leading company under the Ministry of Trade, Industry and Energy's M.AX (Manufacturing AI Transformation) program.

3. Backed by Review Reform and Bulk Purchasing, China's Drug Licensing Exports Surge 90-Fold

- Key Summary: China's overseas licensing exports of innovative new drugs surged 90-fold from $1.5 billion in 2015 to $135.7 billion last year. This is interpreted as the result of the 2015 pharmaceutical review and approval system reform and the national bulk purchasing system implemented from 2021, which supported mass production systems and price competitiveness. China's HEC Pharm succeeded in penetrating the US insulin market on the back of such support, and half of last year's top 10 licensing deals were signed with Chinese companies. In its 15th Five-Year Plan (2026-2030), China elevated biopharmaceuticals to a national strategic core industry alongside semiconductors and aerospace.

4. Q2 Reverse Direct Sales Jump 39%, Direct Purchases Fall for First Time in 14 Quarters

- Key Summary: Online overseas direct sales (reverse direct purchases) in the second quarter of this year jumped 38.7% year-on-year to 1.2032 trillion won. According to the National Data Agency, this is the highest performance in five years on a second-quarter basis, with cosmetics (745.8 billion won, +45.9%) and clothing and fashion sales rising sharply amid the K-culture craze. By region, growth was most pronounced in the US (+56.8%), followed by China (+25.5%) and Japan (+15.4%). In contrast, domestic consumers' overseas direct purchases fell 2.7% to 2.1166 trillion won, retreating for the first time since the fourth quarter of 2022.

5. In the AI Era, It's Time for "Verification"

- Key Summary: The Morgan Stanley Capital International (MSCI) All Country World Index (ACWI) rose 14.9% in the second quarter, fully recovering its declines from the start of the year, but a June price correction in the Magnificent 7 (M7) highlighted valuation burdens on AI growth expectations. AI-related capital expenditures by hyperscalers such as Amazon, Microsoft, and Alphabet are forecast to reach about $1 trillion by 2027, but there are also suggestions their free cash flow (FCF) could turn negative for the first time next year. The initial public offerings (IPOs) of companies such as Anthropic and OpenAI are cited as a test to gauge the market's risk appetite. Investment criteria are shifting from "expectations" of AI to "verification" of whether it actually generates profits.

6. Haenam National AI Computing Center Breaks Ground, Some Resources to Be Supplied Early Next Year

- Key Summary: The Ministry of Science and ICT and the Korea AI Computing Center (KOACC) held a groundbreaking ceremony for the National AI Computing Center on the 3rd at the Solaseado Enterprise City in Haenam County, South Jeolla Province. With a total project cost of 2.4 trillion won, it plans to build infrastructure with 15,000 graphics processing units (GPUs) by 2028 and expand to 50,000 units by 2030. As a result, from 2027, before completion, some AI computing resources from the Samsung SDS data center will be opened first to resolve the GPU shortage among industry, academia, and research institutions early. It has secured a confirmed 40-megawatt (㎿) power supply from Korea Electric Power Corporation and will apply eco-friendly technologies such as cooling water circulation and recycling.